LIQUIDIA CORP Share Price Today: Live Updates & Key Insights

LIQUIDIA CORP share price today is $36.391, up -2.54%. The stock opened at $36.56 against the previous close of $37.36, with an intraday high of $37.55 and low of $36.27.

LIQUIDIA CORP Share Price Chart

LIQUIDIA CORP

us-stock
To Invest in {{usstockname}}
us-stock

LIQUIDIA CORP Share Price Performance

$36.391 -0.0254(-2.54%) LQDA at 23 Mar 2026 02:01 PM Drug Manufacturers - Specialty & Generic
Lowest Today 36.27
Highest Today 37.55
Today’s Open 36.56
Prev. Close 37.36
52 Week High 46.67
52 Week Low 11.26
Day’s Range: Low 36.27 High 37.55
52-Week Range: Low 11.26 High 46.67
1 day return -
1 Week return +1.9
1 month return +11.21
3 month return +1.76
6 month return +58.9
1 year return +132.52
3 year return +428.92
5 year return +1235.41
10 year return -

LIQUIDIA CORP Institutional Holdings

Farallon Capital Management, L.L.C. 9.82

Caligan Partners LP 9.21

BlackRock Inc 5.93

Vanguard Group Inc 4.56

Findell Capital Management LLC 3.24

The Goldman Sachs Group Inc 3.16

Opaleye Management Inc 2.76

Vanguard Total Stock Mkt Idx Inv 2.32

State Street Corp 2.17

Caprock Group Inc 2.02

TCG Crossover Management, LLC 1.94

D. E. Shaw & Co LP 1.89

Geode Capital Management, LLC 1.84

iShares Russell 2000 ETF 1.77

Jupiter Merian Glb Eq AbsRet I USD Acc 1.39

TANG CAPITAL MANAGEMENT LLC 1.30

Morgan Stanley - Brokerage Accounts 1.14

Citadel Advisors Llc 0.91

Bank of America Corp 0.87

Vanguard Institutional Extnd Mkt Idx Tr 0.84

Buckley Capital Advisors LLC 0.74

Fidelity Small Cap Index 0.71

BOOTHBAY FUND MANAGEMENT, LLC 0.70

Northern Trust Corp 0.68

Charles Schwab Investment Management Inc 0.64

iShares Russell 2000 Growth ETF 0.61

Invesco Pharmaceuticals ETF 0.43

State St Russell Sm/Mid Cp® Indx SL Cl I 0.42

Fidelity Extended Market Index 0.41

Schwab US Small-Cap ETF™ 0.38

Oberweis Micro-Cap 0.36

Oberweis Micro-Cap Growth 0.36

Vanguard Russell 2000 ETF 0.35

Fidelity Small Cap Growth 0.26

Stt Strt®SPDR®S&PKenshoNwEcosComposETF 0.25

State St Russell Sm Cap® Indx SL Cl I 0.24

Federated Hermes MDT SCC Institutional 0.21

Federated Hermes MDT Small Cap Core IS 0.21

State Street® SPDR® S&P® PhrmctlsETF 0.21

iShares US Pharmaceuticals ETF 0.21

LIQUIDIA CORP Market Status

Strong Buy: 6

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 1

LIQUIDIA CORP Fundamentals

Market Cap 3208.25 M

PB Ratio 73.5665

PE Ratio 0.0

Enterprise Value 3213.73 M

Total Assets 327.93 M

Volume 1314614

LIQUIDIA CORP Company Financials

Annual Revenue FY23:18317000 18.3M, FY22:15935000 15.9M, FY21:12853345 12.9M, FY20:739628 0.7M, FY19:8072120 8.1M

Annual Profit FY23:15728000 15.7M, FY22:13076000 13.1M, FY21:9830434 9.8M, FY20:501916 0.5M, FY19:7264928 7.3M

Annual Net worth FY23:-57585000 -57.6M, FY22:-38365000 -38.4M, FY21:-29781809 -29.8M, FY20:-57491188 -57.5M, FY19:-46389335 -46.4M

Quarterly Revenue Q3/2025:54342000 54.3M, Q2/2025:8837000 8.8M, Q1/2025:3120000 3.1M, Q3/2024:4448000 4.4M, Q2/2024:3659000 3.7M

Quarterly Profit Q3/2025:51169000 51.2M, Q2/2025:7545000 7.5M, Q1/2025:1603000 1.6M, Q3/2024:2883000 2.9M, Q2/2024:2166000 2.2M

Quarterly Net worth Q3/2025:-3533000 -3.5M, Q2/2025:-41579000 -41.6M, Q1/2025:-38367000 -38.4M, Q3/2024:-23155000 -23.2M, Q2/2024:-27942000 -27.9M

About LIQUIDIA CORP & investment objective

Company Information Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.

Organisation Drug Manufacturers - Specialty & Generic

Employees 216

Industry Drug Manufacturers - Specialty & Generic

CEO Dr. Roger A. Jeffs Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

LIQUIDIA CORP FAQs

What is the share price of LIQUIDIA CORP today?

The current share price of LIQUIDIA CORP is $36.391.

Can I buy LIQUIDIA CORP shares in India?

Yes, Indian investors can buy LIQUIDIA CORP shares by opening an international trading and demat account with Motilal Oswal.

How to buy LIQUIDIA CORP shares in India?

You can easily invest in LIQUIDIA CORP shares from India by:

Can I buy fractional shares of LIQUIDIA CORP?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of LIQUIDIA CORP?

LIQUIDIA CORP has a market cap of $3208.25 M.

In which sector does LIQUIDIA CORP belong?

LIQUIDIA CORP operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in LIQUIDIA CORP stocks?

To invest, you typically need:

What is the PE and PB ratio of LIQUIDIA CORP?

The PE ratio of LIQUIDIA CORP is N/A and the PB ratio is 73.57.